Collaboration and License Agreements - Sarepta Therapeutics, Inc. (Details) - Sarepta - Sarepta Collaboration Agreement $ in Millions	Nov. 25, 2024 USD ($) program
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Cash receivable under collaboration agreement	$ 500.0
Equity investment	325.0
Additional cash receivable under collaboration agreement	250.0
Annual installment	$ 50.0
Annual installments period	5 years
Enrollment related milestone payments	$ 300.0
Number of collaboration programs \| program	13
Minimum
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Development milestone payments	$ 110.0
Sales-related milestone payments	$ 500.0
Maximum
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Number of new target programs \| program	6
Development milestone payments	$ 180.0
Sales-related milestone payments	$ 700.0

Additional Cash Receivable Under Collaboration Agreement

No definition available.

Name:	arwr_AdditionalCashReceivableUnderCollaborationAgreement
Namespace Prefix:	arwr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Cash receivable as upfront payment due under collaboration agreement.

+ References

No definition available.

+ Details

Name:	arwr_CashReceivableUnderCollaborationAgreement
Namespace Prefix:	arwr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Cash Receivable Under Collaboration Agreement, Annual Installments

+ References

No definition available.

+ Details

Name:	arwr_CashReceivableUnderCollaborationAgreementAnnualInstallments
Namespace Prefix:	arwr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Cash Receivable Under Collaboration Agreement, Annual Installments Period

+ References

No definition available.

+ Details

Name:	arwr_CashReceivableUnderCollaborationAgreementAnnualInstallmentsPeriod
Namespace Prefix:	arwr_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Development Milestone Payments

+ References

No definition available.

+ Details

Name:	arwr_DevelopmentMilestonePayments
Namespace Prefix:	arwr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Enrollment Related Milestone Payments

+ References

No definition available.

+ Details

Name:	arwr_EnrollmentRelatedMilestonePayments
Namespace Prefix:	arwr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Number Of Collaboration Programs

+ References

No definition available.

+ Details

Name:	arwr_NumberOfCollaborationPrograms
Namespace Prefix:	arwr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Number Of New Target Programs

+ References

No definition available.

+ Details

Name:	arwr_NumberOfNewTargetPrograms
Namespace Prefix:	arwr_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Sales-related milestone payments.

+ References

No definition available.

+ Details

Name:	arwr_SalesRelatedMilestonePayments
Namespace Prefix:	arwr_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 100
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-100

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 944
-SubTopic 80
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480078/944-80-55-14

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 944
-SubTopic 80
-Name Accounting Standards Codification
-Section 55
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480078/944-80-55-9

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(1)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 1A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482736/825-10-45-1A

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(1)(6))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

+ Details

Name:	us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Details

Name:	srt_CounterpartyNameAxis=arwr_SareptaMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=arwr_SareptaCollaborationAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: